Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Depression in multiple sclerosis associated with interferon beta-1a (Rebif).

× No keyword cloud information.

8 in total

1. Relationship between disease-modifying therapy and depression in multiple sclerosis.

Authors: Stephen S Kirzinger; Jason Jones; Angela Siegwald; Andrew Bryce Crush
Journal: Int J MS Care Date: 2013

Review 2. Depression in multiple sclerosis: a review.

Authors: R J Siegert; D A Abernethy
Journal: J Neurol Neurosurg Psychiatry Date: 2005-04 Impact factor: 10.154

3. (+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors.

Authors: Eva M Medina-Rodriguez; Kenner C Rice; Eléonore Beurel; Richard S Jope
Journal: Brain Behav Immun Date: 2020-08-26 Impact factor: 7.217

4. Gene expression profiling in postmortem prefrontal cortex of major depressive disorder.

Authors: Hyo Jung Kang; David H Adams; Arthur Simen; Birgitte B Simen; Grazyna Rajkowska; Craig A Stockmeier; James C Overholser; Herbert Y Meltzer; George J Jurjus; Lisa C Konick; Samuel S Newton; Ronald S Duman
Journal: J Neurosci Date: 2007-11-28 Impact factor: 6.167

5. Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis.

Authors: Antonietta Gentile; Francesca De Vito; Diego Fresegna; Alessandra Musella; Fabio Buttari; Silvia Bullitta; Georgia Mandolesi; Diego Centonze
Journal: Front Cell Neurosci Date: 2015-06-25 Impact factor: 5.505

6. An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists.

Authors: Annette Kolb-Mäurer; Cord Sunderkötter; Borries Kukowski; Sven G Meuth
Journal: BMC Neurol Date: 2019-06-15 Impact factor: 2.474

Review 7. Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications.

Authors: Parisa Ghasemiyeh; Negar Mortazavi; Iman Karimzadeh; Afsaneh Vazin; Laleh Mahmoudi; Ebrahim Moghimi-Sarani; Ashkan MohammadSadeghi; Mina Shahisavandi; Ali Kheradmand; Soliman Mohammadi-Samani
Journal: Iran J Pharm Res Date: 2021 Impact factor: 1.696

8. Melatonin acts as antioxidant and improves sleep in MS patients.

Authors: Monika Adamczyk-Sowa; Krystyna Pierzchala; Pawel Sowa; Sebastian Mucha; Izabela Sadowska-Bartosz; Jowita Adamczyk; Marcin Hartel
Journal: Neurochem Res Date: 2014-06-30 Impact factor: 3.996

8 in total